PLX Pharma

17/07/2017

PLx has developed a novel oral GI safe NSAID drug delivery system (PLx Guard™) thatthrough a lipid-based complex, makesNSAIDs more lipophilic and therefore facilitates the delivery through the duodenal mucosa. Its most advanced product is a new formulation of aspirin -PL2200 Aspirin- which is bioequivalent to regularaspirin andhas demonstrated a significantly lower ulceration rate compared with immediate releaseaspirin (70% less ulcers).The product has the potential to become the new aspirin standard of care for patients most at risk for cardiovascular disease.

www.plxpharma.com

Esto es un sidebar...

Recent Comments

    Archives

    Categories

    • No categories